Newsroom

Houston Methodist Hospital was named to U.S. News & World Report’s Honor Roll for the eighth time and is the No. 1 hospital in Texas. This also is the 32nd year in a row that Houston Methodist Hospital was ranked in at least one specialty. Read more.

 

Houston Methodist researchers are part of a national consortium funded by an award from the U.S. Government’s Advanced Research Projects Agency for Health to develop a vaccine against two of the most common and destructive strains of herpesviruses that latently infect a majority of Americans and can lead to acute infections, multiple forms of cancer, autoimmune disease and birth defects. Read more. 

 

Houston Methodist researchers have developed an advanced mathematical model that predicts how novel treatment combinations could significantly significantly improve treatment efficacy and extend progression-free survival for patients with non-small-cell lung cancer, the most common type of lung cancer. Read more.